Endotrophin Levels Are Associated with Allograft Outcomes in Kidney Transplant Recipients

Nadja Sparding, Federica Genovese, Daniel Guldager Kring Rasmussen, Morten A Karsdal, Nicoline V Krogstrup, Marie Bodilsen Nielsen, Mads Hornum, Subagini Nagarajah, Henrik Birn, Bente Jespersen, Martin Tepel, Rikke Nørregaard, The CONTEXT Study Group

Research output: Contribution to journalJournal articleResearchpeer-review

2 Downloads (Pure)


Early prediction of kidney graft function may assist clinical management, and for this, reliable non-invasive biomarkers are needed. We evaluated endotrophin (ETP), a novel non-invasive biomarker of collagen type VI formation, as a prognostic marker in kidney transplant recipients. ETP levels were measured with the PRO-C6 ELISA in the plasma (P-ETP) of 218 and urine (U-ETP/Cr) of 172 kidney transplant recipients, one (D1) and five (D5) days, as well as three (M3) and twelve (M12) months, after transplantation. P-ETP and U-ETP/Cr at D1 (P-ETP AUC = 0.86, p < 0.0001; U-ETP/Cr AUC = 0.70, p = 0.0002) were independent markers of delayed graft function (DGF) and P-ETP at D1 had an odds ratio of 6.3 (p < 0.0001) for DGF when adjusted for plasma creatinine. The results for P-ETP at D1 were confirmed in a validation cohort of 146 transplant recipients (AUC = 0.92, p < 0.0001). U-ETP/Cr at M3 was negatively associated with kidney graft function at M12 (p = 0.007). This study suggests that ETP at D1 can identify patients at risk of delayed graft function and that U-ETP/Cr at M3 can predict the future status of the allograft. Thus, measuring collagen type VI formation could aid in predicting graft function in kidney transplant recipients.

Original languageEnglish
Article number792
Issue number5
Publication statusPublished - 5. May 2023


Dive into the research topics of 'Endotrophin Levels Are Associated with Allograft Outcomes in Kidney Transplant Recipients'. Together they form a unique fingerprint.

Cite this